Skip to main content

Table 6 Mean (SEM) percentage changes from baseline in Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in PwMS with low disability (EDSS < 4.0) and high disability (EDSS > =4.0)

From: Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study

 

1 month

3 months

6 months

 

EDSS < 4.0

EDSS > =4.0

EDSS < 4.0

EDSS > =4.0

EDSS < 4.0

EDSS > =4.0

MSSES-Function

3.2% (1.9)

5.4% (7.7)

−2.7% (5.1)

1.9% (9.6)

2.5% (3.0)

0.2% (9.5)

MSSES-Control

6.5% (6.5)

13.3% (10.4)

5.8% (6.5)

11.0% (16.6)

23.8%* (8.1)

22.9% (17.7)

IPA-Limitations

−6.3% (3.9)

−2.0% (3.0)

−6.1%** (3.0)

−0.6% (4.3)

−4.8% (4.0)

−1.3% (4.0)

IPA-Problems

−4.2% (4.2)

−2.9% (3.1)

−8.8%** (4.3)

−3.7% (4.0)

−1.3% (5.3)

−3.1% (4.1)

  1. *, P < 0.01; **, 0.05 < P < 0.06 (comparisons with baseline).